1. Impact of Intensive Therapy With Continuous Subcutaneous Insulin Infusion on Quality of Life in Patients With Type 1 Diabetes
- Author
-
Sergio Valdés Hernández, María Teresa Anarte Ortiz, Alberto Machado Romero, Stella González-Romero, Montserrat Gonzalo-Marín, María Soledad Ruiz de Adana Navas, Federico J. C. Soriguer Escofet, Marta Dominguez-Lopez, María José Tapia Guerrero, Gemma Rojo-Martínez, and Francisco Félix Caballero Díaz
- Subjects
Cultural Studies ,Type 1 diabetes ,Pediatrics ,medicine.medical_specialty ,business.industry ,Life satisfaction ,Experimental and Cognitive Psychology ,medicine.disease ,Surgery ,Clinical Psychology ,Locus of control ,Quality of life ,Diabetes mellitus ,medicine ,Anxiety ,In patient ,medicine.symptom ,business ,Social Sciences (miscellaneous) ,Depression (differential diagnoses) - Abstract
The purpose of this research was to study the effects of treatment with continuous subcutaneous insulin infusion (CSII) on quality of life in patients with type 1 diabetes. A quasi-experimental pretest-posttest design was used. Thirty-seven patients were evaluated before and after receiving treatment. The Diabetes Quality of Life Questionnaire, Beck Depression Inventory-II, State-Trait Anxiety Inventory, and Multidimensional Health Locus of Control Scale were applied. Patients treated with CSII reported a significant improvement in their quality of life (better total quality of life, higher diabetes life satisfaction, and less social and vocational concerns) when compared with patients with Multiple Daily Injections. Although some limitations are described, the results of this study show some evidence of positive effect of pump therapy in patients with poor glycemic control prior to pump start.
- Published
- 2010